Skip to content

Family and Social Services Administration

< Back | Agency Home | Submit Events >

Search events. View events.
 

Family and Social Services Administration

Submit Events

Welcome to the IN.gov Calendar. Please use the Help button to the right for any assistance while using the Calendar.

Click for help in using calendar displays. Print the contents of the current screen.

Advanced Search

(New Search)
  From:
  To:

 

 

 


Submit
Entry Details
Notify me if this event changes.Add this event to my personal calendar.Email this entry to a friend.
Go Back
[FSSA] Therapeutics Committee Meeting
Start Date: 8/2/2013Start Time: 9:00 AM
End Date: 8/2/2013
This event recurs every 3 months on the first Friday until 11/1/2013.   Click here to see the series dates.
Entry Description

Therapeutics Committee Meeting
Indiana Government Center South
Conference Center Room A

1. Call to Order-Chair
2. Opening Comments-OMPP
3. Approval of Memoranda, Meetings of May 3, 2013
4. Preferred Drug List: Therapeutic Class Re-Review

  • a. Respiratory
    • i. Antihistamine-Decongestant Combinations, 2nd Generation Antihistamines
    • ii. Antiviral Monoclonal Antibodies
    • iii. Beta Adrenergics and Corticosteroids
    • iv. Beta Agonists
    • v. Bronchodilator Agents, Beta Adrenergic & Anticholinergic Combinations
    • vi. Leukotriene Receptor Antagonists
    • vii. Monoclonal Antibodies to Immunoglobulin E
    • viii. Nasal Antihistamines, Nasal Anti-inflammatory Steroids
    • ix. Oral Inhaled Glucocorticoids
    • x. Phosphodiesterase-4 Inhibitors
    • xi. Pulmonary Antihypertensives – Phosphodiesterase Type 5 Inhibitors
  • b. Anti-infectives
    • i. Antivirals – Anti-herpetic
    • ii. Antivirals – Anti-influenza
    • iii. First- and Third-Generation Cephalosporins
    • iv. Fluoroquinolones
    • v. Hepatitis C Agents
    • vi. Ketolides
    • vii. Macrolides
    • viii. Ophthalmic Antibiotics
    • ix. Oral Non-Systemic Antifungals
    • x. Otic Antibiotics
    • xi. Systemic Antifungals
    • xii. Topical Antifungals
    • xiii. Topical Antivirals
    • xiv. Topical Antiviral and Antiinflammatory Steroid Combinations
    • xv. Vaginal Antimicrobials
  • c. Cardiovascular
    • i. ACE Inhibitors
    • ii. ACE Inhibitors in combination with CCBs
    • iii. ACE Inhibitors in combination with Diuretics
    • iv. ARBs
    • v. ARBs in combination with CCBs
    • vi. ARBs in combination with CCBs and Diuretics
    • vii. ARBs in combination with Diuretics
    • viii. Alpha-Beta Adrenergic Blockers
    • ix. Beta Adrenergic Blockers
    • x. Beta Blockers with Diuretics
    • xi. Calcium Channel Blockers
    • xii. Calcium Channel Blocker with HMG CoA Reductase Inhibitors(Caduet)
    • xiii. Direct Renin Inhibitors
    • xiv. Direct Renin Inhibitors in combination with ARBs
    • xv. Direct Renin Inhibitors in combination with CCBs
    • xvi. Direct Renin Inhibitors in combination with CCBs and Diuretics
    • xvii. Direct Renin Inhibitors in combination with Diuretics
    • xviii. Potassium Sparing Diuretics (Inspra)
  • d. Lipotropics
    • i. Bile Acid Sequestrants
    • ii. Fibric Acid Derivatives
    • iii. HMG CoA Reductase Inhibitors
    • iv. Lipotropics
  • e. Antimigraine Preparations
  • f. Electrolyte Depleters
  • g. MS Agents
5. OTC Drug Formulary Recommendations
6. New Business: DUR Board Approvals
  • • Butrans – Step Therapy Update
  • • Ultram ER – Step Therapy Update
7. Public Comment
8. Other Business
9. Adjourn
Default
Entry Type:
Event
Entry Category:
  • Hearings
  • Meetings
  • IN.gov Category:
  • Family & Health
  • Agency Name
    Family and Social Services Administration

    Calendar Software powered by Active Calendar and Active Data Calendar   
    Select item(s) to Search






    Select item(s) to Search
    Select item(s) to Search

    Select item(s) to Search